CD274 and esophageal squamous cell carcinoma: The preimmunotherapy and postimmunotherapy tissue DNA alterations and TMB in a patient with ESCC who developed HPD were characterized via NGS 387 or 417 gene panel (3DMed, Shanghai, China).18 The PD-L1 expression was measured via SP142 and 22C3 immunohistochemistry assays, respectively.